ACE and coronary artery disorder: These four biomolecule types have applications in the pharmaceutical industry due to their broad panel of bioactivities, such as antibacterial, antifungal, antiprotozoal, anti-inflammatory, anticoagulant, antitumor, antioxidant, and antiviral activities [8,9,10]; (5) long-chain polyunsaturated fatty acids (PUFAs) that play an essential role in metabolic activities [11], coronary heart diseases, arthritis, wound healing, and blood clotting [12,13,14], and (6) peptides [15] which exhibit angiotensin-converting enzyme (ACE) inhibition [16,17,18].